Related Experiment Videos
Protocolized Evaluation of Permissive Blood Pressure Targets Versus Usual Care (PRESSURE): Statistical Analysis Plan
Tommaso Viola1, Julia Broomhall1, Zia Sadique2
1Clinical Trials Unit, Intensive Care National Audit and Research Centre (ICNARC), London, United Kingdom.
Insights
This study outlines the analysis plan for the PRESSURE trial, comparing permissive mean arterial pressure (MAP) targets with usual care in critically ill children. The trial will assess outcomes like mortality and ventilation duration to guide pediatric critical care strategies.
Area of Science:
- Pediatric Critical Care Medicine
- Hemodynamic Management
- Clinical Trial Design
Background:
- Hypotension in critically ill children often requires vasoactive drugs and mechanical ventilation.
- Establishing optimal blood pressure targets is crucial for improving outcomes in pediatric intensive care units (PICUs).
- The Protocolized Evaluation of Permissive Blood Pressure Targets vs. Usual Care (PRESSURE) trial addresses this clinical uncertainty.
Purpose of the Study:
- To detail the prespecified analysis plan for the PRESSURE randomized controlled trial.
- To compare a permissive mean arterial pressure (MAP) target strategy with usual care in critically ill children.
- To evaluate the impact of different MAP targets on mortality, duration of mechanical ventilation, and other key outcomes.
Main Methods:
- A pragmatic, open-label, multicenter, parallel-group randomized controlled trial with an integrated economic evaluation.
- Inclusion criteria: Critically ill infants and children (older than 38 weeks corrected gestational age) up to 16 years, on invasive mechanical ventilation (IMV) and receiving vasoactive drugs.
- Intervention: Adjustment of hemodynamic support to achieve a permissive MAP target greater than the age-specific fifth centile during IMV.
Main Results:
- Primary outcome: Composite of 30-day mortality and duration of IMV, analyzed using a two-sample rank-sum test.
- Secondary outcomes: Mortality at various time points, survival duration, time to liberation from IMV, functional status, renal replacement therapy, and length of stay.
- Health economic analysis: Intention-to-treat principle, reporting incremental costs, quality-adjusted life years, and cost-effectiveness up to 12 months.
Conclusions:
- The results of the PRESSURE trial will be disseminated through peer-reviewed publications and conference presentations.
- This analysis plan ensures rigorous evaluation of a permissive MAP strategy in pediatric critical care.
- Findings will inform clinical practice guidelines for managing hypotension in critically ill children.
Objective:
To describe the prespecified analysis plan for Protocolized Evaluation of Permissive Blood Pressure Targets vs. Usual Care (PRESSURE), a trial comparing a permissive mean arterial pressure (MAP) target above the age-specific fifth centile with usual care in critically ill children.
Design:
Pragmatic, open, multicenter, parallel group randomized controlled trial with integrated economic evaluation.
Setting:
Twenty-one PICUs in the United Kingdom.
Patients:
Infants and children older than 38 weeks corrected gestational age to 16 years, accepted to a participating PICU, on invasive mechanical ventilation (IMV) and receiving vasoactive drugs for hypotension.
Intervention:
Adjustment of hemodynamic support to achieve a permissive MAP target greater than the fifth centile for age during IMV.
Measurements And Main Results:
The primary outcome is a composite 30-day mortality and duration of IMV, and it will be analyzed with a two-sample rank-sum test. Components will also be analyzed separately. Sensitivity analyses will adjust for adherence, and subgroup analyses will test interactions with baseline covariates. Secondary analyses will compare mortality at various time-points, duration of survival, time to liberation from IMV, functional status changes, receipt of renal replacement therapy and length of stay. The health economic analysis will follow the intention-to-treat principle and report the mean (95% CI) incremental costs, quality-adjusted life years and cost-effectiveness up to 12 months.
Conclusions:
Results will be reported following this plan through peer-reviewed publications and conference presentations.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Measurement of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.